University of Patras
Ο ρόλος κυτταροκινών και βιοχημικών οδών ενδοκυττάριας σηματοδότησης στην παθογένεια των φλεγμονωδών αρθρίτιδων
Abstract
dc:descriptionIL-27 is a cytokine mainly produced by antigen presenting cells and is comprised of p28 and EBI3 subunits. IL-27 activates the Jak-STAT signaling pathway and has both anti- and pro-inflammatory functions. The main pro-inflammatory function of IL-27 is the initiation of Th1 differentiation. We have also found that IL-27 primes human monocytes for more robust responses to TLR-ligands. The dominant anti-inflammatory functions of IL-27 are: 1) the inhibition of Th1, Th2 and Th17 differentiation and 2) the production of IL-10 by lymphocytes. While the functions of IL-27 in the course of infections are well-known, the potential role of IL-27 in chronic inflammatory diseases, like Rheumatoid Arthritis (RA), is still unclear. In our current study we have found that TNF-α stimulates production of IL-27 from monocytes and macrophages and this is a potential explanation for the reported expression of IL-27 in synovial tissues from patients with RA. We have also found that IL-27 has potent anti-inflammatory functions by inhibiting the effects of TNF-α and IL-1β on human monocytes and macrophages. In this context we hypothesize that IL-27 represents a feed-back inhibition mechanism that aims to restrain inflammation. Additionally, we observed that IL-27 is a potent inhibitor of human osteoclastogenesis by down-regulating the expression of RANK and TREM-2 on osteoclast precursors and abrogating RANKL-mediated activation of MAPK and NFκ-B pathways and induction of NFATc1 and c-jun. Our observations suggest that IL-27, by targeting concurrently inflammation and joint destruction, could be a potential attractive therapeutic strategy for RA. The main limitation for this perspective is that inflammatory stimuli (including synovial fluids derived from RA patients, TNF-α and IL-1β) render monocytes and macrophages refractory to the regulatory functions of IL-27. We have found that: 1) synovial macrophages derived from RA do not respond to IL-27 and 2) TNF-α and IL-1β inhibit IL-27 functions by a p38-dependent mechanism and by down-regulating expression of IL-27 receptor respectively. In rheumatoid arthritis, within the inflammed synovium, p38 is active and the cytokines TNF-α and IL-1β are abundant. In this context, we believe that these inflammatory stimuli render cells refractory to the anti-inflammatory factors that are expressed within the synovial microenvironment (including IL-27, IL-10 and TGF-β), contributing to the perpetuation of joint inflammation.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kalliolias, Georgios
- Καλλιόλιας, Γεώργιος
Subjects
dc:subject × 18- Φλεγμονώδεις αρθρίτιδες
- Ρευματοειδής αρθρίτιδα
- Κυτταροκίνες
- Ιντερλευκίνη 27
- Φλεγμονές
- Οστικές διαβρώσεις
- Οστεοκλαστογένεση
- Inflammatory arthritis
- Rheumatoid arthritis
- Cytokines
- Interleukin 27
- Inflammation
- Bone erosions
- Osteoclastogenesis
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26445